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Abstract:
Cardiovascular disease (CVD) prevalence and mortality are rapidly 
increasing globally and this burden, especially in premature CVD death, 
is disproportionally felt in low-and middle-income countries (LMIC)1. We 
know, in addition, that most current armed conflicts and resultant 
population displacement occur in LMICs 2. There is also evidence that 
factors associated with increased CVD risk, such as tobacco and alcohol 
use, are heightened as people cope with conflict and the post-conflict 
environment 1,3. Recent reviews have shown that intense emotion, 
especially bereavement, may trigger heart attacks, but most of these 
studies have been conducted in stable settings 4.  So, although it may 
seem logical that CVD morbidity and mortality would increase in armed 
conflict settings, it is surprising that there is such limited evidence to 
date in this area. 
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Cardiovascular disease (CVD) prevalence and mortality are rapidly increasing globally and 
the burden, especially of premature CVD death, is disproportionally felt in low-and middle-
income countries (LMIC)1. We know, in addition, that most current armed conflicts and 
resultant population displacement occur in LMICs 2. There is also evidence that factors 
associated with increased CVD risk, such as tobacco and alcohol use, are heightened as 
people cope with conflict and the post-conflict environment 1,3. Recent reviews have shown 
that intense emotion, especially bereavement, may trigger heart attacks, but most of these 
studies have been conducted in stable settings 4.  So, although it may seem logical that CVD 
morbidity and mortality would increase in armed conflict settings, it is surprising that there is 
such limited evidence to date in this area. 
This first published systematic review to examine current evidence on the association 
between armed conflict and cardiovascular disease risk by Jawad et al. is both timely and 
important 5. The authors sought to address the question: “What is the association between 
armed conflict and CVD risk for civilians in LMICs, compared to civilians with less or no 
exposure to armed conflict?” They reported on 65 quantitative studies (covering 23 armed 
conflicts), which included a comparator group or examined outcomes over time.  The authors 
descriptively summarised the studies using harvest diagrams, grouping by risk factor, setting 
and date of publication. They found evidence that armed conflict is associated with overt 
illness, including increased coronary heart disease, cerebrovascular, and endocrine diseases; 
and with an increase in CVD risk factors: blood pressure, lipids, alcohol, and tobacco use. In 
addition, the added risk may become evident both during periods of active conflict and in the 
acute and chronic post-conflict period. 
The authors succeeded in clearly summarising the existing research. The main limitations of 
this review relate to the quality of the evidence itself. Among the papers meeting their 
inclusion criteria, we highlight the following limitations: basic study design (almost half were 
cross-sectional), low quality (only 10% were considered high quality), poor measurement of 
outcomes (for example, over half used self-report or didn’t specify how outcomes were 
measured), lack of exploration of causal pathways (potentially useful to design preventive 
interventions), and lack of studies including refugees or relevant regions like the Middle East 
(approximately half of the included studies were derived from just three conflict settings in the 
Balkans and Colombia). As pointed out by the authors, the important inconsistency in their 
findings with respect to different outcomes with similar causal pathways (an increase in 
mortality from chronic ischaemic heart disease but no change in the effect on myocardial 
infarction, angina pectoris or chronic ischaemic chronic disease) may reflect methodological 
shortcomings of the included studies.
The authors make sensible recommendations for conducting future, more robust research, 
which will address some of the limitations of the current evidence base. They suggest we 
focus on: using better outcome measurement, improving management of confounding, and 
increasing the use of control arms or quasi-experimental study designs such as interrupted 
time series. 
This review and a recent review of diabetes care in humanitarian crises both highlight the 
impact of the increasing global burden of noncommunicable diseases (NCDs) on crisis 
settings and support advocacy work to bring NCDs, including CVD and the excess crisis-
associated risks, squarely onto the agendas of humanitarian and development agencies, 
funders and the research community 6. In addition to better characterising the impact of 
conflict on CVD risk, it is also vital to conduct high quality research to improve the clinical care 
and programmatic response for people with CVD in conflict settings.  Although the evidence 
base is growing, there has been limited evidence on effective interventions or guidance for 
CVD (and NCDs in general) in humanitarian settings7. For example, the WHO PEN guide is 
limited in scope and humanitarian actors, such as MSF, acknowledge that their current 
guidelines could be adapted and simplified 8,9. 
A research roadmap could be designed around the response of humanitarian organisations to 
CVD (and other NCDs) in crisis settings. Among the main research priorities we highlight:
1) Rapid assessment tools: We do not know the pre-conflict burden of CVD in most crisis 
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contexts. Therefore, some simple and reliable rapid assessment tools could be valuable for 
informing humanitarian organisations operations in specific settings. Guidance for NCD care 
providers on adapting the response by stage and character of humanitarian crisis (acute 
emergency, stable or unstable protracted conflict or post-conflict) and by the underlying state 
and resilience of the health system in the conflict-affected area (fragile vs. more mature 
health system) may also be useful.
2) Simple diagnostic tools and approaches: The diagnosis of CVD requires investigations – 
involving equipment, personnel and training – that are not widely available, accessible or 
affordable in low-income settings with fragile health systems. So, we need to develop and test 
feasible, accurate and context-adapted point-of-care diagnostic tools and approaches. Such 
approaches may assist, for example, in distinguishing CVD-induced chest pain or shortness 
of breath from sputum negative TB at primary care level in countries with a high TB burden. 
3) Individual risk stratification: People with established CVD, or those at high risk, are 
particularly susceptible to exacerbations or acute events triggered by stress or treatment 
interruption. A more solid, evidence-based risk stratifying approach could help to target 
interventions according to risk, for example, prioritising high-risk groups and urgent 
interventions during th  emergency phase of a crisis.  This may mean simply investing more 
in identifying people with diabetes and chronic kidney disease, both groups with elevated 
CVD risk.
4) Appropriate models of care: We echo the authors’ call for the post-conflict (or inter-conflict) 
reconstruction phase to include low resource, primary level preventive interventions for CVD. 
Identifying and achieving good blood pressure and glycaemic control among people with 
hypertension and diabetes, taking a CVD risk management approach and providing good 
quality CVD secondary prevention care warrant a clear focus. Ideally, NCD interventions in 
general should be designed using a health systems-based approach, with a person-centred 
care focus, while applying the learning from humanitarian organisations’ decades of work on 
chronic HIV care. Empowering nurses and other non-medical health worker cadres to 
diagnose and manage stable patients, empowering patients to self-care, decentralising 
aspects of care to community level (e.g. monitoring, dispensing or delivery of medications), 
and utilising fixed dose combination drugs for hypertension and CVD secondary prevention 
may all play a part in such interventions.  Importantly, humanitarian interventions that target 
CVD should be integrated with other chronic conditions, such as diabetes, asthma and HIV; 
integrated into pre-existing primary care where possible; and integrated across health system 
levels and sites, which are linked by robust referral pathways. Additionally, it would seem 
sensible to integrate mental health and psychosocial support with other aspects of care to 
address some of the stress-related CVD risk associated with conflict.  Although the suggested 
approaches for models of care listed above look promising, we need to conduct robust 
implementation research (using mixed methods) to better understand what works, for whom, 
and in which crisis contexts. 
5) Ensuring availability and affordability of essential medicines and technologies: An NCD 
model of care will only work if essential medicines and technologies are available, accessible 
and affordable. Supply and access are often limited at baseline and worsen in an emergency, 
when supply chains may be disrupted.  In working to address this, from 2017, the Interagency 
Emergency Health Kit (IEHK), designed to provide for the primary care needs of 10,000 
people for approximately three months in post-emergency settings, has included medications 
to treat acute NCD exacerbations. In addition, a specific modular NCD emergency health kit 
is currently being piloted in Iraq and Syria10. Further research is needed to document the 
effectiveness of this strategy and to explore other financing and procurement approaches to 
ensure availability and affordability in the longer term. 
There are some crosscutting issues to be considered across all the proposed research areas. 
Firstly, collaboration of key stakeholders is vital. These include: humanitarian and 
development actors, academics, international agencies, governments, people affected by 
conflicts and the private sector. Secondly, conducting research in conflict settings involves 
ethical and logistical challenges, so we need to develop innovative methodological 
approaches to conduct robust research in these settings. Finally, there is a need for more 
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4
economic evaluations to ensure the efficiency of responses to NCD needs in humanitarian 
crises. 
To conclude, while calling for improved research in this area, we acknowledge the significant 
work already underway by humanitarian actors and UN bodies to address the burden of 
NCDs in crisis settings. We suggest focussing on what works, both by promoting the delivery 
of proven, cost effective CVD interventions and by supporting governments to address CVD 
risk factors through community level prevention strategies and through alcohol, tobacco and 
food policy strengthening.  The aim is to minimise the impact of distress and disruption on 
people with CVD in crises and to build better systems to keep hearts healthy into the future.
We thank Dr Helen Bygrave, Médecins sans Frontières, for her review and helpful comments 
and humanitarian NGO colleagues with whom we collaborate.
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